A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.
Manufactured by
China
Shanghai B&C Biological Technology Co., Ltd., established in 2005, is a high-tech enterprise specializing in medical equipment and reagent R&D, manufacturing, sales, and service. ISO13485/ISO9001 certified with multiple patents, the company focuses on cardiovascular disease diagnostics, infectious disease diagnostics, automation instruments, and precision medicine. Since 2016, B&C has been a wholly-owned subsidiary of Skyray Instrument (Stock: 300165).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 2 relevant products
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
Beijing Zhongjian Antai Diagnostic Co., Ltd.
China · 1 relevant product
ZIODIA Co., Ltd.
South Korea · 1 relevant product
Xenta Biomedical Science Co.,Ltd
China · 4 relevant products
Vitrosens Biyoteknoloji Anonim Sirketi
Türkiye · 1 relevant product
Shenzhen YHLO Biotech Co., Ltd.
China · 1 relevant product
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 1 relevant product
Chengdu Illumaxbio Technology Co.,LTD
China · 1 relevant product
20 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 38 closest product alternatives
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.
Guangzhou Wondfo Biotech Co., Ltd. · China
Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.
Beijing Zhongjian Antai Diagnostic Co., Ltd. · China
Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.
ZIODIA Co., Ltd. · South Korea
A platform for immune diagnosis devices based on Quantum Dot fluorescence measurement mode technology. It includes Quantum Dot labeled detection kits for enhanced sensitivity, precise analysis, and multiplex analysis capabilities. The platform offers both Gold Type and Quantum Dot Type kits with sensitivity down to ng/ml levels and 500-1,000 fold higher accuracy compared to gold standard detection methods.
Xenta Biomedical Science Co.,Ltd · China
An immunolayer chromatography technology platform utilizing fluorescence detection for rapid diagnostic testing. Provides high sensitivity across multiple analyte categories including thyroid markers.
Vitrosens Biyoteknoloji Anonim Sirketi · Türkiye
Immunofluorescence-based diagnostic platform for infectious disease detection providing accurate and fast results.
Xenta Biomedical Science Co.,Ltd · China
An easy-to-operate platform that supports whole blood direct testing with results available in as fast as 3 minutes. It offers high detection throughput of up to 450 tests per hour, includes a built-in thermal printer, and features dedicated tuberculosis detection functionality to provide efficient and reliable testing solutions for primary healthcare settings.
Shenzhen YHLO Biotech Co., Ltd. · China
An indirect immunofluorescence technology platform for serological testing and antibody detection. The system is utilized for diagnosis of autoimmune and infectious diseases through fluorescence-based immunoassay methodology.
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Quantum dot fluorescence-based platform for in vitro diagnostic applications. Supports development of various immunological assays with enhanced optical properties and batch consistency.
Xenta Biomedical Science Co.,Ltd · China
A proprietary dry-phase photoactivated chemiluminescence technology platform for point-of-care testing. Covers cardiovascular, inflammatory, tumor marker, hormone, and infectious disease diagnostics.
Shenzhen Microprofit Biotech Co., Ltd · China
Point-of-care immunofluorescence test platform for rapid pathogen detection. Utilizes fluorescence technology for sensitive and specific clinical diagnostics.
26 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products